Pivotal Study of the Velocity™ pAVF System

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 126 participants.

Also called NCT07153939

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 126 participants (planned count) (from the registry)
Sponsor
Venova Medical (from the registry)
Registry
  • NCT NCT07153939
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07153939. Allocation not applicable; no masking; primary purpose treatment. Start 2025-10-21 (actual); primary completion 2026-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pivotal Study of the Velocity™ pAVF System
Acronym
VENOS-3
Condition
Hemodialysis Access
Condition
Arteriovenous Fistula
Condition
End Stage Renal Disease (ESRD)
Intervention (Device)
Velocity Percutaneous Arteriovenous Fistula
Lead sponsor
Venova Medical (class: industry)

Record details

Record id
cardio:ct-nct07153939
Content hash
37d247931a8e99ee7e22070a218e214937b6ca1613db28c8f2fda189e622d501